A Study in Adult Patients With Nonalcoholic Steatohepatitis Who Also Have Type 2 Diabetes

Summary

The purpose of this study is to assess the effect of TEV-45478, as compared with placebo, on liver health and liver fat content in patients with T2DM who also have Nonalcoholic Steatohepatitis (NASH).

Timeline

Start

2016-09-30

Primary completion

2018-01-31

Completion

2018-02-28

Outcome

Outcome not reported

Stopped (Business): “Business decision”

Drugs

Indications